Sample size estimation for non-inferiority trials of time-to-event data

Pharmaceutical Statistics

Volumn 7, Issue 4, 2008, Pages 236-244

  Crisp, Adam ^a   Curtis, Paula ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Hazard ratio; Sample size; Survival data; Uon inferiority

Indexed keywords

ARTICLE; CALCULATION; CLINICAL RESEARCH; CONCEPTUAL FRAMEWORK; DATA ANALYSIS; HAZARD RATIO; MATHEMATICAL ANALYSIS; SAMPLE SIZE; SIMULATION; VARIANCE;

CLINICAL TRIALS AS TOPIC; FOLLOW-UP STUDIES; HUMANS; RESEARCH DESIGN; SAMPLE SIZE; TIME FACTORS;

EID: 57849108057     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.292     Document Type: Article

References (14)

1. Freedman LS. Tables of the number of patients required in clinical trials using the logrank test. Statistics in Medicine 1982; 1:121-129.
2. Collett D. Modelling Survival Data in Medical Research. Chapman & Hall: London, 1994.
3. Lachin JM, Foulkes MA. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance and stratification. Biometrics 1986; 42:507-519.
4. D'Agostino RB (ed.). Statistics in Medicine 2003; 22(2):165-336.
5. D'Agostino RB (ed.). Statistics in Medicine 2006; 25(7):1097-1273
6. Brunner E, Schumacher M (eds). Biometrical Journal 2005; 47(1):5-107.
7. Freitag G. Methods for assessing noninferiority with censored data. Biometrical Journal 2005; 47(1):88-98.
8. Bristol DR. Planning survival studies to compare a treatment to an active control. Journal of Biopharmaceutical Statistics 1993; 3(2):153-158.
9. Rothmann M, Li N, Chen G, Chi GYH, Temple R, Tsou H. Design and analysis of non-inferiority mortality trials in oncology. Statistics in Medicine 2003; 22:239-264.
10. Chow SC, Shao J, Wang H. Sample Size Calculation in Clinical Research. Marcel Dekker: New York, NY, 2003.
11. Laster LL, Johnson MF, Kotler ML. Non-inferiority trials: the 'at least as good as' criterion with dichotomous data. Statistics in Medicine 2006; 25(7):1115-1130.
12. Rubinstein LV, Gail MH, Santner TJ. Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation. Journal of Chronic Diseases 1981; 34:469-479.
13. George SL, Desu MM. Planning the size and duration of a clinical trial studying the time to some critical event. Journal of Chronic Diseases 1974; 27:15-24.
14. DeGroot MH. Probability and Statistics (2nd edn). Addison-Wesley: Reading, MA, 1986.